Studying the mechanism of (-)Schisandrin B on the treatment of Parkinson's disease via ATG16L1/NLRP3 signaling pathway
- LI, M. (Participant)
Activity: Conference/talk/lecture/symposium/speech/workshop, etc › Event organized by non-HKBU units
Activity: Conference/talk/lecture/symposium/speech/workshop, etc › Event organized by non-HKBU units